Diabetics To Touch 325 Million By 2025

Released on = June 20, 2006, 9:40 pm

Press Release Author = RNCOS

Industry = Pharmaceuticals

Press Release Summary = Obesity and inactive lifestyle plus a few other factors,
will take the number of diabetic patients, all over the world, to an alarming 325Mn
by the year 2025.

Press Release Body = Sedentary lifestyle and obesity being the main reasons, more
and more people are falling prey to the deadly disease know as "diabetes".

Out of the total 165Mn diabetic patients across the world, about 18Mn are in USA
alone. Approximately 5% of these patients suffer from Type 1 diabetes, primarily
caused by the destruction of insulin producing cells (the islet cells). However rest
of them have Type 2 diabetes, characterized by abnormal insulin secretion and/or
insulin resistance.

In its recently published market research report named, "New Developments in Insulin
Delivery Systems (2006)", RNCOS has provided the following information about the
looming prevalence of diabetes:

§ Number of diabetic patients is set to cross 200Mn by the year 2010 all over the
world, while the same is expected to rise to a stunning 325Mn by 2025.
§ There'll be more than two fold growth in Africa, Middle East, South-East Asia, and
Eastern Mediterranean by the year 2025. Regions such as Europe, North America, and
South & Central America and Western Pacific aren't far behind.

As per experts at RNCOS, "An increase of 170% in the cases of diabetes is foreseen
in developing countries and will jump to 42% in developed countries in the near
future".

Salient Features of this Research
§ Analysis of current market trends.
§ Comprehensive discussion about the leading edge technologies.
§ Scope of main insulin delivery systems across the globe.
§ Profile discussion of the key players in this sector.
§ Discussion about various challenges & opportunities in front of the industry.
§ Classification of the main factors, influencing the latest developments in insulin
delivery systems.

Profile discussion of key players including Novo Nordisk A/S, Eli Lilly and Company,
Sanofi-Aventis, and GlaxoSmithKline plc is covered in the report.

About RNCOS:
RNCOS, incorporated in 2002, provides Market Research Reports for your business
needs and aims to put an end to your information pursuit. Our expertise in gathering
global business information for industry research, corporate training, growth
consulting, and business consulting, brings reputed companies and firms to us for
business enhancement solutions. We can be your one-stop-shop for Industry research
information and niche market analysis.

To purchase your copy: http://www.rncos.com/Report/IM040.htm
For more information about the report please visit www.rncos.com


Web Site = http://www.rncos.com

Contact Details = RNCOS
Shushmul Maheshwari
Head of Business Development
29, 1st Floor, Patparganj Industrial area, Delhi 92
91-11-4214-1229
info@rncos.com

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •